RNA
Atrium Therapeutics, Inc.
8.00$
+1.7%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -526.5% | – | – | – | – | – | – | – | – | – | – | |
| – | +8.7% | +4.2% | +7.2% | +3.3% | +3.9% | +6.4% | -1,095.9% | – | -88.4% | +23.8% | +127.2% | – | |
| – | +0.3% | +4.7% | +24.3% | +10.0% | +0.4% | +25.3% | -0.4% | +7.7% | -81.3% | +243.8% | -92.7% | – | |
| – | +829.4% | -115.0% | – | – | -202.6% | – | – | – | – | -581.2% | – | – | |
| – | -6.5% | +6.0% | -42.0% | +220.9% | +129.8% | -4.2% | -10.9% | +16.3% | -77.4% | +138.7% | -98.3% | – | |
| – | – | -164.2% | +739.4% | +75.5% | -86.7% | – | +18.0% | -417.0% | -99.9% | +138.7% | +9,031.9% | – | |
| – | +79,627.5% | +1,121.2% | +14.7% | -23.3% | -96.0% | -85.9% | +94.8% | +22,438.2% | -97.6% | +1,397.7% | -100.0% | – | |
| – | – | +188.0% | -62.7% | -292.4% | – | – | -130.0% | – | -69.5% | +727.8% | -172.9% | – | |
| – | – | -555.9% | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.